Patents Examined by Navin Natnithithadha
-
Patent number: 12779118Abstract: A wearable, conductive textile patch is provided that may include any of a number of features for monitoring body analytes and/or delivering fluids to a body. In one embodiment of the invention, a single, patch-mounted system monitors glucose levels of a diabetic person and provides appropriate doses of insulin in response to the glucose measurements. A hand-held user interface can be provided for wirelessly controlling the system and/or receiving information from it. Conductive pathways can be formed in the fabric of the patch. Components that can be integrated into the flexible patch include a power source, controller, transmitter, antenna, temperature and other sensors, fluid pump, infusion set, electrical pathways, switches, controls, electrodes, connectors, resistors and other circuit elements. Such components can be embedded, interwoven or coated on to the flexible patch instead of or in addition to surface mounting. Methods associated with use of the flexible patch system are also covered.Type: GrantFiled: June 28, 2023Date of Patent: November 3, 2026Assignee: Abbott Diabetes Care Inc.Inventor: Gary Ashley Stafford
-
Patent number: 12778470Abstract: This sensor has a probe inserted into a living body, and measures an analyte, wherein the probe has a substrate, an electrode formed on the substrate, a reagent layer formed on the electrode, a first protective film formed on the reagent layer, and a second protective film which is thinner than the first protective film and formed on the first protective film.Type: GrantFiled: February 26, 2021Date of Patent: November 3, 2026Assignee: PHC Holdings CorporationInventors: Fuminori Kutsuna, Masaki Fujiwara, Masami Tomioka, Toshihiro Ikeda, Masatomo Matsui, Makoto Sueyoshi
-
Method and system for providing integrated analyte monitoring and infusion system therapy management
Patent number: 12776405Abstract: Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided.Type: GrantFiled: April 4, 2024Date of Patent: October 27, 2026Assignee: Abbott Diabetes Care Inc.Inventor: R. Curtis Jennewine -
Patent number: 12773120Abstract: A method and a device for diagnostic of skin cancer and other mammalian skin tissue pathologies are described. The method relies on determination of pathological changes in tissue vascularization and capillary blood flow. The device uses photonic emitters and detectors to characterize temporal and spatial changes in blood flow in response to external perturbation such as external mechanical force or temperature change.Type: GrantFiled: October 5, 2023Date of Patent: October 27, 2026Assignee: VeriSkin, Inc.Inventors: Mirianas Chachisvilis, Carl Frederick Edman, Eugene Tu
-
Patent number: 12765809Abstract: The present invention provides a sensor unit in which a sensor inserted into a user's skin along with a needle can be kept being stably inserted into the skin without being affected by the movement of the needle in the process of the needle being separated from the user's skin. The sensor unit according to the present invention, which is attached to the user's skin to measure the user's biometric information, comprises: a sensor that includes a sensor body and an insertion part connected to the sensor body so as to be placed on a different plane from the sensor body and capable of being inserted into the user's skin; a housing base that includes a housing base hole through which the insertion part passes, and supports the sensor body; a housing cap that is coupled to the housing base and covers the sensor body; and a retention protrusion that protrudes from the housing cap to contact the sensor in order to prevent the insertion part from moving backward toward the housing cap.Type: GrantFiled: November 11, 2021Date of Patent: October 20, 2026Assignee: I-SENS, INC.Inventors: Hyun Ho Choi, Goang Yel Ryu, Ji Hoon Wang
-
Patent number: 12765785Abstract: A method for optimizing a pulse wave velocity measurement system, comprising: (i) transmitting a pulse from a pulse generator of a first sensor component of the pulse wave velocity measurement system, wherein the first sensor component further comprises a first clock, and wherein the pulse is transmitted from the pulse generator at a known transmission time based on the first clock; (ii) receiving the transmitted pulse by a pulse receiver of a second sensor component of the pulse wave velocity measurement system, wherein the second sensor component further comprises a second clock, and wherein the pulse is received at a known receipt time based on the second clock; (iii) comparing the known transmission time to the known receipt time; and (iv) optimizing, based on the comparison, the pulse wave velocity measurement system.Type: GrantFiled: May 31, 2023Date of Patent: October 20, 2026Assignee: Koninklijke Philips N.V.Inventors: Koen Theo Johan de Groot, Jozef Hubertus Gelissen, Carlijn Andrea Vernooij, Wilhelmus Franciscus Johannes Verhaegh, Linda Maria Eerikainen, Alberto Giovanni Bonomi, Reinder Haakma
-
Patent number: 12751649Abstract: Methods and Devices to monitor the level of at least one analyte are provided.Type: GrantFiled: December 7, 2020Date of Patent: October 6, 2026Assignee: ABBOTT DIABETES CARE INC.Inventors: Marc Barry Taub, Jolyon Robert Bugler, Thomas A. Peyser
-
Patent number: 12745966Abstract: An electronic sphygmomanometer includes a cuff pressure control unit, a pressure detection unit, and a blood pressure measurement unit that extracts a pulse wave signal and measures blood pressure based on the pulse wave signal. A pulse wave interval calculation unit obtains a data group representing pulse wave intervals based on the pulse wave signal obtained only in one depressurization process for a subject for each one measurement occasion. A determination unit aggregates data groups for three or more measurement occasions to obtain an average value of the pulse wave intervals, and determines whether or not there is a possibility that atrial fibrillation occurred based on whether or not there is data of an irregular pulse wave exceeding an allowable range with respect to the average value.Type: GrantFiled: June 5, 2023Date of Patent: September 29, 2026Assignee: OMRON HEALTHCARE CO., LTD.Inventors: Yukiya Sawanoi, Terumasa Naito, Hiroyuki Kanda, Yuta Kudo, Tatsunori Ito
-
Patent number: 12745893Abstract: Oxygen saturation is calculated on the basis of a calculation value with reference to an oxygen saturation calculation table TBL. A specific colorant concentration of a specific colorant other than hemoglobin is calculated on the basis of B3 image signals and G1 image signals. Whether or not a first difference D1 between the specific colorant concentration and a reference concentration is in a specific range is monitored. A correction notification related to correction of the oxygen saturation calculation table TBL is performed on the basis of a result of the monitoring of the specific colorant concentration.Type: GrantFiled: November 27, 2023Date of Patent: September 29, 2026Assignee: FUJIFILM CorporationInventor: Takaaki Saito
-
Patent number: 12733838Abstract: There is provided a method that includes receiving pulse oximetry measurements (SpO2) of a patient's peripheral arterial blood oxygen saturation during a first time period, and receiving breathing samples of the patient. The method further includes determining, using breathing samples of the patient, oxygen partial pressure measurements (PAO2,) and carbon dioxide partial pressure measurements (PACO2) from exhaled air of the patient during a steady-state breathing of the patient during the first time period.Type: GrantFiled: October 13, 2021Date of Patent: September 15, 2026Assignee: MediPines CorporationInventors: Steve Lee, Youngjae Lee
-
Patent number: 12724918Abstract: A method, system, and computer program product detect and react to neural signals. The method includes monitoring the neural signals, which are collected from a user by a neural-computer interface (NCI) device. The method further includes detecting, based on the monitoring, an inhibitory signal in the neural signals and determining, in response to the detecting, that the inhibitory signal is aligned with an emotionally salient signal. Additionally, the method includes generating a notification in response to the determining that the inhibitory signal is aligned with the emotionally salient signal. The notification is displayed at an output device.Type: GrantFiled: November 6, 2023Date of Patent: September 1, 2026Assignee: International Business Machines CorporationInventors: Sara E Berger, Marc P. Yvon, Neil Delima
-
Patent number: 12708320Abstract: One embodiment provides a method, including: obtaining EEG data from one or more single channel EEG sensor worn by a user; classifying, using a processor, the EEG data as one of nominal and abnormal; and providing an indication associated with a classification of the EEG data. Other embodiments are described and claimed.Type: GrantFiled: October 16, 2023Date of Patent: August 18, 2026Assignee: Epitel, Inc.Inventors: Michael K. Elwood, Mitchell A. Frankel, Mark J. Lehmkuhle, Jean M. Wheeler, Robert Lingstuyl, Erin M. West, Tyler D. McGrath
-
Patent number: 12697034Abstract: A medical device (100) determines a resistance parameter (107), of a patient to be treated, indicating a peripheral vascular resistance. A reception module (110) is configured to receive a pulsatile signal (112). The pulsatile signal indicates a blood pressure curve (114), especially an arterial blood pressure curve, or a blood volume curve. A reading module (120) is connected to the reception module and is configured to read a number of predefined curve parameters (124) from the received pulsatile signal and to provide corresponding, read measured values (134) for the number of predefined curve parameters. A calculation module (130) is connected to the reading module and is configured to calculate the resistance parameter of the patient with the use of a predefined estimation function (136) based on the read measured values and on a predefined parameter (135) indicating the cardiac output of the patient and to output same.Type: GrantFiled: September 21, 2021Date of Patent: August 4, 2026Assignee: Drägerwerk AG & Co. KGaAInventors: Birgit Stender, Michael Kircher
-
Patent number: 12690806Abstract: A sleep monitoring system and a sleep monitoring method are provided. The sleep monitoring system includes a receiver, a transmitter, a storage and a processing circuit. The receiver and the transmitter are disposed in the target field, and the transmitter transmits a wireless detection signal to the target field. The user is located between the receiver and the transmitter, and the receiver receives the wireless detection signal over multiple communication links. The processing circuit is electrically connected to the receiver and the storage, and analyzes a change of the wireless detection signal within a predetermined time, so as to detect a sleep time of a user within the predetermined time, and obtains a sleep quality of the user within the sleep time.Type: GrantFiled: November 22, 2023Date of Patent: July 28, 2026Assignee: WISTRON NEWEB CORPORATIONInventors: Yi-An Chen, Chui-Chu Cheng, Tsung-Yu Ho
-
Patent number: 12678039Abstract: Virtual reality, VR, headset-based electronic systems that can be used to perform visual field tests. The systems may improve the sensitivity, consistency, and case of application of the visual field test. Other aspects are also described.Type: GrantFiled: December 12, 2023Date of Patent: July 14, 2026Assignee: Verily Health Inc.Inventors: Supriyo Sinha, Kirk Gossage, Dimitri Azar
-
Patent number: 12678021Abstract: A bleeding detection system may receive, from an image capture system during a surgical procedure, a first frame of data of a scene of a surgical site and identify, based on the first frame, a region of blood in the scene. The system may receive, from the image capture system subsequent to receiving the first frame, a second frame of data of the scene, the second frame including data representative of the region of blood. The system may estimate, based on the first frame and the second frame, motion of blood flow in the region of blood and generate data representative of a combined image comprising the second frame and a visual indicator indicating the motion of blood flow in the region of blood. The system may transmit, during the surgical procedure, the data representative of the combined image to a display unit for display of the combined image.Type: GrantFiled: August 12, 2020Date of Patent: July 14, 2026Assignee: Intuitive Surgical Operations, Inc.Inventors: Wenyi Zhao, Catherine J. Mohr, Jonathan M. Sorger
-
Patent number: 12672836Abstract: Methods of respiration compensation including detecting a position of a catheter proximate a target within a patient, performing a local registration to update a displayed relative position and orientation of the catheter and the target in a three-dimensional model, detecting movement of a plurality of sensors, determining a respiration waveform from the detected movement of the plurality of sensors, and indicating on a user-interface a period during which advancement of a biopsy or therapy tool from the catheter is most likely to intersect the target, wherein the period corresponds to a portion of the respiration waveform during which the movement of the plurality of sensors is within a desired range.Type: GrantFiled: July 21, 2022Date of Patent: July 7, 2026Assignee: Covidien LPInventors: Evgeni Kopel, John W. Komp, Scott E.M. Frushour, Scott Robert Tiesma, William J. Dickhans, Christopher Michael Kolin
-
Patent number: 12667266Abstract: A continuous blood pressure measurement device includes a cuff airbag pneumatically connected to an inflation/deflation unit and a pressure detection unit. The device also comprises at least one light-emitting diode, at least one photodiode, and a volume detection unit configured to convert photoplethysmogram signals into arterial volume signals. A control unit precisely tracks a predefined setpoint to achieve arterial unloading based on a volume compensation method. An extraction unit reconstructs a high-fidelity arterial blood pressure waveform and accurately determines systolic, diastolic, mean arterial pressures, and heart rate.Type: GrantFiled: April 6, 2025Date of Patent: June 30, 2026Assignee: JB HealthTechInventor: Sharon Xiaorong Wang
-
Patent number: 12661069Abstract: A system or method for validating an unvalidated cardiovascular parameter monitor can include receiving a plurality of reference cardiovascular parameter datasets, each reference cardiovascular parameter dataset associated with a patient of a plurality of patients; receiving a plurality of test cardiovascular parameter measurements, each test cardiovascular parameter measurement includes a cardiovascular parameter measured for a patient of the plurality of patients; and validating the cardiovascular parameter monitor based on an analysis of the plurality of reference cardiovascular measurements and the plurality of test cardiovascular parameter measurement.Type: GrantFiled: July 20, 2023Date of Patent: June 23, 2026Assignee: Midmark CorporationInventor: Tuhin Sinha
-
Patent number: 12642464Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.Type: GrantFiled: July 3, 2025Date of Patent: June 2, 2026Assignee: ABBOTT DIABETES CARE INC.Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam